We are live on ! Find out more
VIVO

Meridian Bioscience Inc

Delisted

VIVO was delisted on the 30th of January, 2023.

177 hedge funds and large institutions have $615M invested in Meridian Bioscience Inc in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 69 increasing their positions, 49 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

657% more call options, than puts

Call options by funds: $2.13M | Put options by funds: $281K

41% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 49

14% more capital invested

Capital invested by funds: $541M → $615M (+$74.1M)

5% less funds holding

Funds holding: 186177 (-9)

27% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 22

Holders
177
Holders Change
-9
Holders Change %
-4.84%
% of All Funds
4.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
69
Reduced
49
Closed
22
Calls
$2.13M
Puts
$281K
Net Calls
+$1.85M
Net Calls Change
+$1.38M
Name Holding Trade Value Shares
Change
Change in
Stake
GC
76
Guggenheim Capital
Illinois
$904K +$242K +16,239 +40%
Victory Capital Management
77
Victory Capital Management
Texas
$875K +$16.2K +1,085 +2%
Bank of Montreal
78
Bank of Montreal
Ontario, Canada
$850K +$712K +47,750 +835%
NSIM
79
North Star Investment Management
Illinois
$841K
BC
80
Brinker Capital
Pennsylvania
$828K +$49.7K +3,330 +7%
Royal Bank of Canada
81
Royal Bank of Canada
Ontario, Canada
$813K +$28.3K +1,898 +4%
State of New Jersey Common Pension Fund D
82
State of New Jersey Common Pension Fund D
New Jersey
$795K
AIM
83
Assured Investment Management
New York
$776K -$132K -8,855 -15%
Tudor Investment Corp
84
Tudor Investment Corp
Connecticut
$766K +$132K +8,865 +23%
First Trust Advisors
85
First Trust Advisors
Illinois
$764K +$110K +7,348 +18%
Schroder Investment Management Group
86
Schroder Investment Management Group
United Kingdom
$732K -$109K -7,277 -14%
USAA
87
United Services Automobile Association
Texas
$712K
Comerica Bank
88
Comerica Bank
Texas
$706K +$8.23K +552 +1%
LPIC
89
LeJeune Puetz Investment Counsel
Michigan
$700K -$104K -7,000 -14%
AG
90
Aperio Group
California
$683K -$127K -8,504 -17%
State Board of Administration of Florida Retirement System
91
State Board of Administration of Florida Retirement System
Florida
$657K
SRAM
92
Stone Ridge Asset Management
New York
$597K -$12.8K -855 -2%
Wellington Management Group
93
Wellington Management Group
Massachusetts
$574K
AIG
94
American International Group
New York
$511K +$81.8K +5,482 +21%
Manulife (Manufacturers Life Insurance)
95
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$508K -$3.43K -230 -0.7%
MWAC
96
Mariner Wealth Advisors (Cincinnati)
Ohio
$500K +$1.27K +85 +0.3%
State of Tennessee, Department of Treasury
97
State of Tennessee, Department of Treasury
Tennessee
$467K -$15.3K -1,027 -3%
Thrivent Financial for Lutherans
98
Thrivent Financial for Lutherans
Minnesota
$462K +$27.3K +1,831 +7%
Barclays
99
Barclays
United Kingdom
$460K -$24K -1,606 -5%
CCMINC
100
Cardinal Capital Management Inc (North Carolina)
North Carolina
$460K +$8.1K +543 +2%

VIVO Hedge Fund Activity: Q2 2018 in Review

177 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2018, worth a combined $615M — up 14% from $541M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of VIVO and 16 opened new positions — a net loss of 6 holders — while 49 trimmed existing stakes and 69 added.

The largest buyer was BlackRock, adding an estimated $7.74M. The largest seller was Millennium Management, cutting an estimated $5.9M.

  • 177 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2018, down from 186 in Q1 2018.
  • Funds reported $615M of Meridian Bioscience Inc stock for Q2 2018, up 14% quarter-over-quarter.
  • 16 funds opened new Meridian Bioscience Inc positions in Q2 2018 and 22 closed out, a net change of -6 holders.
  • The largest Meridian Bioscience Inc buyer in Q2 2018 was BlackRock, an estimated $7.74M added.
  • The largest Meridian Bioscience Inc seller in Q2 2018 was Millennium Management, an estimated $5.9M sold.

Based on aggregated 13F filings for Q2 2018.